19-50467696-C-T
Variant summary
Our verdict is Likely benign. The variant received -4 ACMG points: 0P and 4B. BP4_Strong
The NM_001308429.2(GARIN5A):c.673G>A(p.Gly225Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000282 in 1,593,368 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G225D) has been classified as Uncertain significance.
Frequency
Consequence
NM_001308429.2 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -4 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes  0.000112  AC: 17AN: 152178Hom.:  0  Cov.: 31 show subpopulations 
GnomAD2 exomes  AF:  0.0000751  AC: 16AN: 213102 AF XY:  0.0000781   show subpopulations 
GnomAD4 exome  AF:  0.0000194  AC: 28AN: 1441190Hom.:  0  Cov.: 31 AF XY:  0.0000196  AC XY: 14AN XY: 715082 show subpopulations 
Age Distribution
GnomAD4 genome  0.000112  AC: 17AN: 152178Hom.:  0  Cov.: 31 AF XY:  0.000148  AC XY: 11AN XY: 74330 show subpopulations 
Age Distribution
ClinVar
Submissions by phenotype
not specified    Uncertain:1 
The c.625G>A (p.G209S) alteration is located in exon 4 (coding exon 4) of the FAM71E1 gene. This alteration results from a G to A substitution at nucleotide position 625, causing the glycine (G) at amino acid position 209 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source: 
Splicing
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at